PSP
- Company typePrivate
- Founded2022
- HeadquartersTokyo, Japan
- Headcount501–1,000
- GTM typeB2B
- OfferingSoftware
PSP firmographics
Firmographics- Name
- PSP
- Legal name
- PSP株式会社 (PSP Corporation)
- Website
- https://psp.co.jp
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
PSP industry classification
Industry- Product category
- Medical Imaging Software (Healthcare IT / PACS)
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Picture Archiving & Communication Systems (PACS) (HLACALAA)
- akta.pro secondary industries
- Radiology Information Systems (RIS) (HLACALAB), Teleradiology Platforms & Reading Workflow (HLACALAK), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), Radiology Reporting, Dictation & Structured Reporting (HLACALAF)
Keywords
Where PSP is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices26 records
Markets served
PSP business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations, Supply Chain
Revenue model
- Cloud PACS (NOBORI) subscription: Monthly/annual subscription fees for cloud-based medical image management services. NOBORI-CUBE hardware provided as rental equipment with zero initial investment required from customers. Subscription covers data center storage, viewer software, support, and maintenance.
- On-premise PACS / Application software: Sale of on-premise PACS software licenses and related applications (EV Insite series viewer software, RIS, mammography PACS) primarily to large-scale facilities. May include professional services for implementation and customization.
- NOBORI PAL platform services: Platform fees and per-use charges for AI diagnostic support services, regional healthcare coordination (TONARI), emergency external image reference (TSUNAGU), and other cloud services accessed through the NOBORI PAL ecosystem.
- NOBORI PHR (patient-facing app): PHR services provided to medical institutions for patient-facing digital health record delivery, often bundled with core cloud PACS subscription.
- Professional services and implementation: System adoption engineering, on-site installation, customization, training, and ongoing technical support services provided by field engineering teams.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
PSP product offering
Product offeringCore offering
PSP Corporation develops and operates cloud-based medical image management systems, primarily the NOBORI Cloud PACS (Picture Archiving and Communication System), for hospitals, clinics, and health checkup centers in Japan. The portfolio includes on-premises DICOM viewers (EV Insite series), a cloud service platform (NOBORI PAL) with AI diagnostic support tools, a patient-facing Personal Health Record (PHR) smartphone app, a cloud-based Radiology Information System (RIS), a digital pathology PACS, and supplementary services for radiation dose management, regional healthcare coordination, and emergency image reference.
Product overview
PSP Corporation offers a platform-plus-modules architecture centered on cloud PACS NOBORI and on-premises/standalone EV Insite viewers, with an ecosystem of applications (Viewer, Report, RIS, Mobile Viewer, Pathology PACS) and the NOBORI PAL service platform hosting AI diagnostic tools and regional coordination services. The core NOBORI PACS manages medical images across radiology, pathology, and other modalities via cloud infrastructure with East/West Japan dual data centers. NOBORI PHR extends the platform to patients via a smartphone app. The portfolio spans: PACS/NOBORI (cloud), EV Insite (on-prem), NOBORI PAL (platform), NOBORI PAL AI (AI hub), NOBORI PHR (patient app), and supplementary services (TONARI, TSUNAGU, MINCADI, 医知悟, RIS, etc.). After the 2022 merger of PSP and NOBORI, the combined entity serves approximately 2,500 facilities with 22%+ domestic PACS market share. Strategic expansions include digital pathology (2024), Kyoto Prefecture AI lung cancer screening (2026), electronic medical record sharing (2026), and the PERICAN perioperative management app (2026).
Differentiator
Problem solved
Functional benefit
Products and services
- NOBORI Cloud PACS Cloud-based Picture Archiving and Communication System (PACS) for storing, managing, and archiving medical images (CT, MRI, X-ray, ultrasound, endoscopy, mammography). Uses NOBORI-CUBE appliance servers with dual East/West Japan data center storage, encrypted and secret-dispersed data protection, and zero initial investment plus monthly subscription pricing. Targeted at hospitals, clinics, and health checkup centers in Japan.
- EV Insite (EV Insite R / S / M) On-premises and standalone DICOM viewer software family. EV Insite R is a reading workstation viewer; EV Insite S is a standalone viewer for laptops; EV Insite M is a mammography-specific viewer. Designed for hospitals and radiology departments.
- NOBORI PAL Platform Cloud service platform built on NOBORI infrastructure. Provides an ecosystem of third-party and PSP-developed services including AI diagnostic tools, 3D processing, case databases, conference tools, voice recognition, and regional healthcare coordination services. Sold to medical institutions on monthly or usage-based pricing.
- NOBORI PHR Personal Health Record (PHR) smartphone application enabling patients of partner hospitals to view medical images, test results, prescriptions, appointment histories, and health records. Supports myNumber portal linkage, QR code data import from lab measurement devices, family sharing, and multi-institution health data aggregation. Sold B2B to medical institutions for patient-facing deployment.
- NOBORI PAL AI AI diagnostic support platform within NOBORI PAL, hosting multiple AI tools including EIRL aneurysm (brain aneurysm), EIRL Chest Screening (lung nodules), VUNO Med-LungCT, Ali-M3 COVID-19, Canon Medical Stroke package, ClearRead chest X-ray, and Temporal Subtraction For Bone. Used by radiologists and radiology departments.
- NOBORI for Pathology (Cloud Pathology PACS) Cloud pathology PACS for digitized Whole Slide Imaging (WSI) management, AI-powered pathological image analysis (integrated Medmain pathology AI), remote telepathology consultation, and cross-departmental image integration. Unifies pathology data with CT/MRI/endoscopy images within NOBORI. Sold to hospitals and pathology laboratories.
- MINCADI (Cloud Radiation Dose Management) Cloud-based radiation exposure dose management system tracking patient radiation dose per exam and enabling inter-facility comparison for optimization of imaging parameters against national Diagnostic Reference Levels. Sold to hospitals and imaging centers.
- 医知悟 (Remote Image Diagnosis Support) Remote image diagnosis support service allowing radiologists to submit remote reading requests directly from the NOBORI PACS reporting system, with images transmitted via ICHIGO's anonymized, secure infrastructure. Sold to hospitals and radiology practices needing remote reading capacity.
- Kyoto Prefecture Lung Cancer Screening AI Program AI chest X-ray diagnostic support program for Kyoto Prefecture lung cancer screening. Jointly developed with Kyoto Medical Association and Preferred Networks. Displays 'No Findings' for low-abnormality-suspicion cases to reduce radiologist workload in mass screening. Deployed via NOBORI PACS infrastructure.
Quantifiable outcome
- Zero initial investment model: NOBORI-CUBE rental hardware, no on-premise server purchase required, monthly subscription model
- +5 more outcomes
Companies that use PSP
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
PSP technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration26 records
AI capability15 records
Feature9 records
PSP partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major and minor.
- Preferred Networks (株式会社Preferred Networks / PFN)corePFN collaborated with Kyoto Medical Association and PSP to develop an AI-powered chest X-ray diagnostic support program for Kyoto Prefecture's lung cancer screening program. PFN's proprietary AI model was trained with a focus on normal cases (no abnormal findings) and displays 'No Findings' to support radiologists. PFN brings expertise in medical image analysis accumulated over 10+ years including Kaggle competition wins.
- Regulus Inc. (レギュラス株式会社)corePSP acquired all shares of Regulus, making it a wholly-owned subsidiary in June 2024. Regulus is an imaging CRO specializing in medical imaging for clinical trials and research. The acquisition strengthens PSP's presence in clinical research and trial imaging services and enables synergy with PHR ePRO services and program medical device evaluation.
- Life Data Initiative ((一社)ライフデータイニシアティブ / LDI)majorLDI and NTT Data partnered with PSP to provide medical image data (X-rays, CT, MRI, etc.) under Japan's Next Generation Medical Infrastructure Act. PSP collects medical image data from healthcare institutions, which LDI and NTT Data anonymize and provide to research institutions, pharma companies, and medical device developers for program medical device development.
- NTT Data (株式会社NTTデータ)majorNTT Data serves as a designated medical information handling contractor for anonymizing and distributing medical image data under Japan's Next Generation Medical Infrastructure Act, working with LDI and PSP to provide medical image data to research and development entities.
- M3 AI Inc. (エムスリーAI株式会社)coreJoint AI platform NOBORI PAL AI development and distribution. M3 AI provides an AI platform aggregating multiple diagnostic AI tools, with PSP providing the cloud PACS infrastructure and distribution. M3 AI's AI services are available through Canon Medical's sales channel and PSP's direct sales. Products include VUNO Med LungCT, Ali-M3 COVID-19 analysis, and other AI diagnostic tools.
- Specimen Measurement Room Liaison Council (検体測定室連携協議会)minorCollaboration with Abbott Diagnostics Medical, Jichi Medical University, and other partners to enable QR code-based data linkage between point-of-care blood testing devices (Abbott Afinion 2, Roche cobas b 101) and NOBORI PHR app, allowing patients to view blood test results in their PHR app.
- Medmain Inc. (メドメイン株式会社)corePSP invested 300 million yen in Medmain and entered a capital and business alliance for digital pathology. Medmain provides pathology AI software (PidPort) and WSI digitization services. In February 2026, PSP and TechMatrix agreed to acquire majority control (70%+ equity) of Medmain for approximately 2.3 billion yen. Medmain's AI covers 7 organs and 12 disease models. PSP provides cloud PACS infrastructure for Medmain's digital pathology platform.
- OPERe Inc. (株式会社OPERe)minorSix-company collaborative 'Smart Hospital Management' exhibit at Modern Hospital Show 2022, where PSP showcased patient referral management solutions as part of the hospital admission-discharge workflow demonstration.
- A-Line Co., Ltd. (株式会社A-Line)minorGroup subsidiary providing MINCADI cloud radiation dose management service. A-Line is part of the PSP Group alongside ICHIGO LLC (合同会社医知悟), providing remote image diagnosis infrastructure services.
- Splink Inc. (株式会社Splink)minorThree-party collaboration with Millennia for the 'Brain Healthcare Program' combining Splink's Brain Life Imaging AI (hippocampal volumetry), Millennia's cognitive function scale (Atama no Kenko Check), and PSP's NOBORI PHR for comprehensive brain health monitoring.
- Millennia Inc. (株式会社ミレニア)minorPartnership for cognitive function assessment integration with NOBORI PHR, enabling patients to track cognitive health data alongside other medical records. Also part of the Brain Healthcare Program with Splink.
- Canon Medical Systems Corporation (キヤノンメディカルシステムズ株式会社)coreStrategic partnership for healthcare IT solutions. Canon Medical distributes PSP's DICOM viewer software and cloud PACS through its sales network, while PSP distributes Canon Medical's AI analytics and 3D processing technology. The 2024 expanded partnership adds M3 AI products to Canon Medical's distribution scope. Canon Medical's Stroke basic package and other AI tools are integrated into NOBORI PAL AI platform.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
PSP competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Operates the syngo and teamplay imaging IT platforms globally and in Japan. Provides PACS plus AI-driven radiology solutions as part of a broader diagnostic imaging portfolio.
- GE HealthCare: Global enterprise imaging vendor offering PACS, Edison AI platform, and cloud imaging solutions. Competes with PSP across Japanese hospital systems with broader modality and analytics portfolios.
- Canon Medical Systems: Global imaging modality vendor with healthcare IT portfolio that includes its own PACS offerings. Both a strategic partner (distributes PSP's EV Insite R and NOBORI) and a competitor in Japan, with much broader modality and clinical depth.
- Hyland Healthcare: Provides the Acuo enterprise PACS/VNA platform plus broader healthcare content services. Competes with PSP's image management and interoperability capabilities for large hospital system contracts.
- Philips Healthcare: Provides enterprise PACS, advanced visualization, and AI-enabled radiology workflows to Japanese hospitals. Competes on cloud-native imaging informatics while leveraging much larger global R&D and modality base.
Direct peers
- Carestream Health: Provides PACS, RIS, and enterprise imaging IT to hospitals and imaging centers. Competes with PSP in Japan with comparable focus on multi-vendor, cloud-capable imaging informatics.
- FUJIFILM Medical Systems: Largest Japan-based PACS and medical imaging informatics vendor, offering both on-premise and cloud PACS plus AI diagnostic tools. Directly competes with PSP in Japanese hospitals and is the most directly comparable domestic rival.
- Sectra: European cloud-native PACS and enterprise imaging vendor with growing APAC presence. Comparable business model centered on subscription-based, cloud-ready imaging IT and AI integration.
- Konica Minolta Healthcare Japan: Provides PACS, imaging solutions, and diagnostic AI for Japanese healthcare providers. Overlaps with PSP's core PACS plus AI marketplace offering and competes for the same hospital and clinic customers.
Emerging players
- INFINITT Healthcare: Korea-headquartered cloud PACS and AI imaging vendor expanding internationally. Comparable product focus and overlapping competition for cloud PACS contracts in Asia-Pacific hospitals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
PSP compliance and trust
Trust signalCompliance4 records
PSP financial estimates
Financial estimateRevenue estimate
Valuation estimate
PSP leadership team
Management profileNumber of profiles
Profiles2 records
PSP subsidiaries and ownership
Company hierarchySubsidiaries5 records
PSP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PSP M&A and investment
M&A and investmentM&A1 record
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PSP
What does PSP do?
PSP Corporation develops and operates cloud-based medical image management systems, primarily the NOBORI Cloud PACS (Picture Archiving and Communication System), for hospitals, clinics, and health checkup centers in Japan. The portfolio includes on-premises DICOM viewers (EV Insite series), a cloud service platform (NOBORI PAL) with AI diagnostic support tools, a patient-facing Personal Health Record (PHR) smartphone app, a cloud-based Radiology Information System (RIS), a digital pathology PACS, and supplementary services for radiation dose management, regional healthcare coordination, and emergency image reference.
Is PSP a public or private company?
PSP is a private company. It is classified as corporate owned and is currently operating.
When was PSP founded?
PSP was founded in 2022. It employs 501 to 1,000 people.
Where is PSP based?
PSP is headquartered in Tokyo, Japan, in the Asia region.
How does PSP make money?
Five revenue lines are on record. Cloud PACS (NOBORI) subscription is the primary driver. The others are on-premise PACS / Application software, NOBORI PAL platform services, NOBORI PHR (patient-facing app) and professional services and implementation.
Who are PSP's main competitors?
Broad incumbents on record are Siemens Healthineers, GE HealthCare, Canon Medical Systems, Hyland Healthcare and Philips Healthcare. Direct peers are Carestream Health, FUJIFILM Medical Systems, Sectra and Konica Minolta Healthcare Japan. INFINITT Healthcare is listed as an emerging player.
Does PSP have an API?
No public API is recorded for PSP.
What industry is PSP in?
PSP's product category is Medical Imaging Software (Healthcare IT / PACS). Its primary akta.pro industry code is HLACALAA, Picture Archiving & Communication Systems (PACS), with a secondary code of HLACALAB, Radiology Information Systems (RIS). Its NAICS code is 5182 and its SIC code is 7370.